Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(559/week)
Manufacturing
(388/week)
Energy
(305/week)
Technology
(408/week)
Other Energy
(276/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tisagenlecleucel
Dec 10, 2017
Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer
Nov 01, 2017
Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease
Oct 31, 2017
Novartis submits application to FDA for Kymriah(TM) (tisagenlecleucel) in adult patients with r/r DLBCL, seeking second indication for first-ever FDA approved CAR-T therapy
Oct 18, 2017
FDA Approves Second LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment
Sep 12, 2017
Companies to Watch as Biotech Makes a Comeback in 2017
Aug 30, 2017
FDA approval brings first gene therapy to the United States
Aug 30, 2017
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (tisagenlecleucel, CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice
Aug 30, 2017
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children's Hospital of Philadelphia
Aug 30, 2017
Multimedia Assets Now Available: Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (tisagenlecleucel, CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice
Aug 30, 2017
First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology
Jul 25, 2017
Cryoport to Support Launch of Potential Treatment for Relapsed/Refractory Acute Lymphoblastic Leukemia
Jun 23, 2017
Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
Jun 07, 2017
Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL
‹‹
Page 2
Latest News
May 15, 2024
Imperial Dade Canada Adds Scale in Canada, Acquires Canpaco, Inc.
May 15, 2024
EM-Power Europe: Flexible Consumers Take the Burden Off the Grid
May 15, 2024
StoneTurn Expands Energy Transition Offering with Subterra Renewables Collaboration
May 15, 2024
JMR Services® and A-Plus P&A Close Previously-Announced Merger and Acquire BCM & Associates, Creating...
May 15, 2024
Easterly Government Properties Announces Close of 49,420 SF Facility in Orlando, Florida to Expand Mission-...
May 15, 2024
Westlake Pipe & Fittings Expands Operations with New Distribution Center in Florida
May 15, 2024
Catalyze Announces Transaction to Support Community Distributed Generation Portfolio
May 15, 2024
Asahi Kasei Announces Port Colborne, Ontario, Canada as Location of Future Lithium-ion Battery Separator Plant
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events